FDA Approval Mifepristone REMS Program Modification Expands Patient Access to Abortion Care | Sheppard Mullin Richter & Hampton LLP

The Food and Drug Administration (the “FDA”) has approved a modification to the Mifepristone Risk Evaluation and Mitigation Strategy (“REMS”) Program, increasing the accessibility of...

Related Keywords

Maryland ,United States ,American , ,Jackson Women Health Organization ,Drug Administration ,Sheppard Mullin Richter Hampton ,Maryland Us District Court ,Us Supreme Court ,American College Of Obstetricians ,American Civil Liberties Union ,Mitigation Strategy Program ,Program Modifications ,Program For Mifeprex ,Sheppard Mullin Richter ,Mifepristone Risk Evaluation ,Mitigation Strategy ,Mifepristone Tablets ,American College ,Health Organization ,Prescriber Agreement Form ,Pharmacy Agreement Form ,Medication Guide ,Patient Agreement Form ,Medical Termination ,Pregnancy Through Ten Weeks Gestation ,Risk Evaluation ,Mitigation Strategies ,Approving Mifepristone ,